{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:49:40Z","timestamp":1778183380949,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/bmt.2016.253","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T13:53:53Z","timestamp":1477317233000},"page":"352-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?"],"prefix":"10.1038","volume":"52","author":[{"given":"P","family":"Dhakal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V R","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"BFbmt2016253_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1076029615598221","volume":"22","author":"O Elsallabi","year":"2016","unstructured":"Elsallabi O, Bhatt VR, Dhakal P, Foster KW, Tendulkar KK . Hematopoietic stem cell transplant-associated thrombotic microangiopathy. Clin Appl Thromb Hemost 2016; 22: 12\u201320.","journal-title":"Clin Appl Thromb Hemost"},{"key":"BFbmt2016253_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","volume":"40","author":"ED Batts","year":"2007","unstructured":"Batts ED, Lazarus HM . Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 2007; 40: 709\u2013719.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016253_CR3","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1681\/ASN.2006020118","volume":"17","author":"S Hingorani","year":"2006","unstructured":"Hingorani S . Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 2006; 17: 1995\u20132005.","journal-title":"J Am Soc Nephrol"},{"key":"BFbmt2016253_CR4","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S . Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 2011; 118: 1452\u20131462.","journal-title":"Blood"},{"key":"BFbmt2016253_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 2010; 90: 918\u2013926.","journal-title":"Transplantation"},{"key":"BFbmt2016253_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1703710","volume":"30","author":"AS Daly","year":"2002","unstructured":"Daly AS, Xenocostas A, Lipton JH . Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002; 30: 709\u2013715.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016253_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/sj.bmt.1705160","volume":"36","author":"MT Martinez","year":"2005","unstructured":"Martinez MT, Bucher C, Stussi G, Heim D, Buser A, Tsakiris DA et al. Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 2005; 36: 993\u20131000.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"BFbmt2016253_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/hon.2310","volume":"35","author":"Yishan Ye","year":"2016","unstructured":"Ye Y, Zheng W, Wang J, Hu Y, Luo Y, Tan Y et al. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study. Hematol Oncol 2016 (e-pub ahead of print 1 June 2016; doi:10.1002\/hon.2310).","journal-title":"Hematological Oncology"},{"key":"BFbmt2016253_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","volume":"19","author":"S Jodele","year":"2013","unstructured":"Jodele S, Hirsch R, Laskin B, Davies S, Witte D, Chima R . Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 2013; 19: 202\u2013207.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016253_CR10","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","volume":"116","author":"JN George","year":"2010","unstructured":"George JN . How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010; 116: 4060\u20134069.","journal-title":"Blood"},{"key":"BFbmt2016253_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","volume":"44","author":"JN George","year":"2004","unstructured":"George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB . Thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion 2004; 44: 294\u2013304.","journal-title":"Transfusion"},{"key":"BFbmt2016253_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","volume":"69","author":"C Choi","year":"2009","unstructured":"Choi C, Schmaier A, Snell M, Lazarus H . Thrombotic microangiopathy in haematopoietic stem cell transplantation. Drugs 2009; 69: 183\u2013198.","journal-title":"Drugs"},{"key":"BFbmt2016253_CR13","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMra1404711","volume":"374","author":"S Hingorani","year":"2016","unstructured":"Hingorani S . Renal complications of hematopoietic-cell transplantation. N Engl J Med 2016; 374: 2256\u20132267.","journal-title":"N Engl J Med"},{"key":"BFbmt2016253_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.blre.2014.09.001","volume":"28","author":"A Verbiest","year":"2014","unstructured":"Verbiest A, Pirenne J, Dierickx D . De novo thrombotic microangiopathy after non-renal solid organ transplantation. Blood Rev 2014; 28: 269\u2013279.","journal-title":"Blood Rev"},{"key":"BFbmt2016253_CR15","first-page":"565","volume":"12","author":"J Chapin","year":"2014","unstructured":"Chapin J, Shore T, Forsberg P, Desman G, Van Besien K, Laurence J . Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. Clin Adv Hematol Oncol 2014; 12: 565\u2013573.","journal-title":"Clin Adv Hematol Oncol"},{"key":"BFbmt2016253_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","volume":"36","author":"N Worel","year":"2007","unstructured":"Worel N, Greinix HT, Leitner G, Mitterbauer M, Rabitsch W, Rosenmayr A et al. ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy. Transfus Apher Sci 2007; 36: 297\u2013304.","journal-title":"Transfus Apher Sci"},{"key":"BFbmt2016253_CR17","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JL Ferrara","year":"2009","unstructured":"Ferrara JL, Levine JE, Reddy P, Holler E . Graft-versus-host disease. Lancet 2009; 373: 1550\u20131561.","journal-title":"Lancet"},{"key":"BFbmt2016253_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.bmt.1702639","volume":"26","author":"T Furlong","year":"2000","unstructured":"Furlong T, Storb R, Anasetti C, Appelbaum F, Deeg H, Doney K et al. Clinical outcome after conversion to FK 506(tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. Bone Marrow Transplant 2000; 26: 985\u2013991.","journal-title":"Bone Marrow Transplant"},{"issue":"feb08 1","key":"BFbmt2016253_CR19","first-page":"bcr2012007351","volume":"2013","author":"N. L. Boyer","year":"2013","unstructured":"Boyer NL, Niven A, Edelman J . Tacrolimus-associated thrombotic microangiopathy in a lung transplant recipient. BMJ Case Rep 2013; bcr2012007351.","journal-title":"Case Reports"},{"key":"BFbmt2016253_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-2004-832714","volume":"25","author":"PN Chhajed","year":"2004","unstructured":"Chhajed PN, Tamm M, Glanville AR . Role of flexible bronchoscopy in lung transplantation. Semin Respir Crit Care Med 2004; 25: 413\u2013423.","journal-title":"Semin Respir Crit Care Med"},{"key":"BFbmt2016253_CR21","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1056\/NEJMra064928","volume":"357","author":"JA Fishman","year":"2007","unstructured":"Fishman JA . Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601\u20132614.","journal-title":"N Engl J Med"},{"key":"BFbmt2016253_CR22","doi-asserted-by":"crossref","unstructured":"Legro IR, Shah S, Kaza V . Tacrolimus induced hemolytic uremic syndrome in a lung transplant patient. Am J Respir Crit Care Med 2010; 181: A5834.","DOI":"10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A5834"},{"key":"BFbmt2016253_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1432-2277.1999.tb00627.x","volume":"12","author":"A Humar","year":"1999","unstructured":"Humar A, Jessurun J, Sharp HL, Gruessner RW . Hemolytic uremic syndrome in small-bowel transplant recipients: the first two case reports. Transpl Int 1999; 12: 387\u2013390.","journal-title":"Transpl Int"},{"key":"BFbmt2016253_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/01.TP.0000092522.36410.D0","volume":"77","author":"AS Paramesh","year":"2004","unstructured":"Paramesh AS, Grosskreutz C, Florman SS, Gondolesi GE, Sharma S, Kaufman SS et al. Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. Transplantation 2004; 77: 129\u2013131.","journal-title":"Transplantation"},{"key":"BFbmt2016253_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","volume":"11","author":"C Cutler","year":"2005","unstructured":"Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E et al. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 551\u2013557.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016253_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 571\u2013575.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016253_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","volume":"38","author":"D Wolff","year":"2006","unstructured":"Wolff D, Wilhelm S, Hahn J, Gentilini C, Hilgendorf I, Steiner B et al. Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. Bone Marrow Transplant 2006; 38: 445\u2013451.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016253_CR28","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.lpm.2011.10.026","volume":"41","author":"JN George","year":"2012","unstructured":"George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lammle B . Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med 2012; 41: e177\u2013e188.","journal-title":"Presse Med"},{"key":"BFbmt2016253_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.bmt.1701830","volume":"24","author":"P Iacopino","year":"1999","unstructured":"Iacopino P, Pucci G, Arcese W, Bosi A, Falda M, Locatelli F et al. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO). Bone Marrow Transplant 1999; 24: 47\u201351.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016253_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","volume":"53","author":"S Jodele","year":"2013","unstructured":"Jodele S, Laskin BL, Goebel J, Khoury JC, Pinkard SL, Carey PM et al. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy? Transfusion 2013; 53: 661\u2013667.","journal-title":"Transfusion"},{"key":"BFbmt2016253_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1055\/s-0034-1376153","volume":"40","author":"M Riedl","year":"2014","unstructured":"Riedl M, Fakhouri F, Le Quintrec M, Noone DG, Jungraithmayr TC, Fremeaux-Bacchi V et al. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 2014; 40: 444\u2013464.","journal-title":"Semin Thromb Hemost"},{"key":"BFbmt2016253_CR32","first-page":"271","volume":"16","author":"R Sarode","year":"1995","unstructured":"Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1995; 16: 271\u2013275.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016253_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","volume":"137","author":"WY Au","year":"2007","unstructured":"Au WY, Ma ES, Lee TL, Ha SY, Fung AT, Lie AK et al. Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. Br J Haematol 2007; 137: 475\u2013478.","journal-title":"Br J Haematol"},{"key":"BFbmt2016253_CR34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/bmt.2008.25","volume":"41","author":"AM Carella","year":"2008","unstructured":"Carella AM, D'Arena G, Greco MM, Nobile M, Cascavilla N . Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura. Bone Marrow Transplant 2008; 41: 1063\u20131065.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016253_CR35","first-page":"72","volume":"122","author":"H Marr","year":"2009","unstructured":"Marr H, McDonald EJ, Merriman E, Smith M, Mangos H, Stoddart C et al. Successful treatment of transplant-associated microangiopathy with rituximab. N Z Med J 2009; 122: 72\u201374.","journal-title":"N Z Med J"},{"key":"BFbmt2016253_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.bmt.1705657","volume":"39","author":"M Ostronoff","year":"2007","unstructured":"Ostronoff M, Ostronoff F, Calixto R, Florencio R, Florencio M, Domingues MC et al. Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant 2007; 39: 649\u2013651.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016253_CR37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","volume":"20","author":"S Jodele","year":"2014","unstructured":"Jodele S, Fukuda T, Vinks A, Mizuno K, Laskin BL, Goebel J et al. Eculizumab therapy in children with severe hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy. Biol Blood Marrow Transplant 2014; 20: 518\u2013525.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016253_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","volume":"12","author":"M Mengel","year":"2012","unstructured":"Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC et al. Banff 2011 meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563\u2013570.","journal-title":"Am J Transplant"},{"key":"BFbmt2016253_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","volume":"8","author":"K Solez","year":"2008","unstructured":"Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753\u2013760.","journal-title":"Am J Transplant"},{"key":"BFbmt2016253_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","volume":"96","author":"BL Laskin","year":"2013","unstructured":"Laskin BL, Maisel J, Goebel J, Yin HJ, Luo G, Khoury JC et al. Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation 2013; 96: 217\u2013223.","journal-title":"Transplantation"},{"key":"BFbmt2016253_CR41","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","volume":"122","author":"S Jodele","year":"2013","unstructured":"Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA et al. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood 2013; 122: 2003\u20132007.","journal-title":"Blood"},{"key":"BFbmt2016253_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","volume":"29","author":"S Jodele","year":"2015","unstructured":"Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 2015; 29: 191\u2013204.","journal-title":"Blood Rev"},{"key":"BFbmt2016253_CR43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood 2014; 124: 645\u2013653.","journal-title":"Blood"},{"key":"BFbmt2016253_CR44","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","volume":"124","author":"M Noris","year":"2014","unstructured":"Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E et al. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. Blood 2014; 124: 1715\u20131726.","journal-title":"Blood"},{"key":"BFbmt2016253_CR45","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1182\/blood-2014-07-590356","volume":"124","author":"V Afshar-Kharghan","year":"2014","unstructured":"Afshar-Kharghan V . COMPLEMENTing the diagnosis of aHUS. Blood 2014; 124: 1699\u20131700.","journal-title":"Blood"},{"key":"BFbmt2016253_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ki.2011.497","volume":"81","author":"D Cohen","year":"2012","unstructured":"Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V et al. Pros and cons for C4d as a biomarker. Kidney Int 2012; 81: 628\u2013639.","journal-title":"Kidney Int"},{"key":"BFbmt2016253_CR47","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","volume":"127","author":"S Jodele","year":"2016","unstructured":"Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC et al. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood 2016; 127: 989\u2013996.","journal-title":"Blood"},{"key":"BFbmt2016253_CR48","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/trf.12859","volume":"55","author":"SS Kim","year":"2014","unstructured":"Kim SS, Patel M, Yum K, Keyzner A . Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options. Transfusion 2014; 55: 452\u2013458.","journal-title":"Transfusion"},{"key":"BFbmt2016253_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","volume":"54","author":"S Jodele","year":"2016","unstructured":"Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G et al. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transfus Apher Sci 2016; 54: 181\u2013190.","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"BFbmt2016253_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1076029615599439","volume":"23","author":"Prajwal Dhakal","year":"2016","unstructured":"Dhakal P, Giri S, Pathak R, Bhatt VR . Eculizumab in transplant-associated thrombotic microangiopathy. Clin Appl Thromb Hemost 2015 (e-pub ahead of print 9 August 2016; doi:10.1177\/1076029615599439).","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"BFbmt2016253_CR51","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","volume":"99","author":"FS de Fontbrune","year":"2015","unstructured":"de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S et al. Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC. Transplantation 2015; 99: 1953\u20131959.","journal-title":"Transplantation"},{"key":"BFbmt2016253_CR52","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/bmt.2016.87","volume":"51","author":"S Vasu","year":"2016","unstructured":"Vasu S, Wu H, Satoskar A, Puto M, Roddy J, Blum W et al. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy. Bone Marrow Transplant 2016; 51: 1241\u20131244.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016253_CR53","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.4081\/hr.2015.6107","volume":"7","author":"C Fern\u00e1ndez","year":"2015","unstructured":"Fern\u00e1ndez C, Lario A, For\u00e9s R, Cabrera R . Eculizumab treatment in a patient with hematopoietic stem cell transplantation-associated thrombotic microangiopathy and steroid-refractory acute graft versus host disease. Hematol Rep 2015; 7: 6107.","journal-title":"Hematol Rep"},{"key":"BFbmt2016253_CR54","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/tri.12551","volume":"28","author":"E Morales","year":"2015","unstructured":"Morales E, Rabasco C, Gutierrez E, Praga M . A case of thrombotic micro\u2010angiopathy after heart transplantation successfully treated with eculizumab. Transpl Int 2015; 28: 878\u2013880.","journal-title":"Transpl Int"},{"key":"BFbmt2016253_CR55","first-page":"425410","volume":"2015","author":"\u00d6G Sevindik","year":"2015","unstructured":"Sevindik \u00d6G, Alacac\u0131o\u011flu \u0130, Katg\u0131 A, Solmaz \u015eM, Acar C, Pi\u015fkin \u00d6 et al. Renal and neurological response with eculizumab in a patient with transplant associated thrombotic microangiopathy after allogeneic hematopoietic progenitor cell transplantation. Case Rep Hematol 2015; 2015: 425410.","journal-title":"Case Rep Hematol"},{"key":"BFbmt2016253_CR56","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006; 355: 1233\u20131243.","journal-title":"N Engl J Med"},{"key":"BFbmt2016253_CR57","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.bbmt.2016.03.032","volume":"22","author":"S Jodele","year":"2016","unstructured":"Jodele S, Dandoy CE, Danziger-Isakov L, Myers KC, El-Bietar J, Nelson A et al. Terminal complement blockade after hematopoietic stem cell transplantation is safe without meningococcal vaccination. Biol Blood Marrow Transplant 2016; 22: 1337\u20131340.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016253_CR58","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/ajt.12032","volume":"13","author":"GH Struijk","year":"2013","unstructured":"Struijk GH, Bouts AHM, Rijkers GT, Kuin EAC, ten Berge IJM, Bemelman FJ . Meningococcal sepsis complicating eculizumab treatment despite prior vaccination. Am J Transplant 2013; 13: 819\u2013820.","journal-title":"Am J Transplant"},{"key":"BFbmt2016253_CR59","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C et al. Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome. N Engl J Med 2013; 368: 2169\u20132181.","journal-title":"N Engl J Med"},{"key":"BFbmt2016253_CR60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V126.23.275.275","volume":"126","author":"E Gavriilaki","year":"2015","unstructured":"Gavriilaki E, Thanassi JA, Yang G, Yuan X, Huang M, Brodsky RA . Small molecule factor D inhibitors block complement activation in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Blood 2015; 126: 275.","journal-title":"Blood"},{"key":"BFbmt2016253_CR61","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/eji.201445070","volume":"45","author":"MP Keizer","year":"2015","unstructured":"Keizer MP, Pouw RB, Kamp AM, Patiwael S, Marsman G, Hart MH et al. TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2. Eur J Immunol 2015; 45: 544\u2013550.","journal-title":"Eur J Immunol"},{"key":"BFbmt2016253_CR62","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1182\/blood-2013-11-536573","volume":"123","author":"AM Risitano","year":"2014","unstructured":"Risitano AM, Ricklin D, Huang Y, Reis ES, Chen H, Ricci P et al. Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria. Blood 2014; 123: 2094\u20132101.","journal-title":"Blood"},{"key":"BFbmt2016253_CR63","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1182\/blood-2014-02-556027","volume":"123","author":"J Shi","year":"2014","unstructured":"Shi J, Rose EL, Singh A, Hussain S, Stagliano NE, Parry GC et al. TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins. Blood 2014; 123: 4015\u20134022.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016253","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T20:29:49Z","timestamp":1749673789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFbmt2016253"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.253","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]},"assertion":[{"value":"1 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}